EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Explainable Artificial Intelligence Framework for Predicting Treatment Outcomes in Age-Related Macular Degeneration

Mini Han Wang iD

Sensors · 11.11.2025 · 25 (22) · 6879

DOI: 10.3390/s25226879 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Sensors, online erschienen am 11.11.2025. Verfasst von Mini Han Wang. Beteiligte Einrichtung: Zhuhai People's Hospital (The Affiliated Hospital of Beijing Institute of Technology, Zhuhai Clinical Medical College of Jinan University), Zhuhai 51…. Hauptthemen laut MEDLINE: Macular Degeneration, Large Language Models. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Age-related macular degeneration (AMD) is a leading cause of irreversible blindness, yet current tools for forecasting treatment outcomes remain limited by either the opacity of deep learning or the rigidity of rule-based systems. To address this gap, we propose a hybrid neuro-symbolic and large language model (LLM) framework that combines mechanistic disease knowledge with multimodal ophthalmic data for explainable AMD treatment prognosis. In a pilot cohort of ten surgically managed AMD patients (six men, four women; mean age 67.8 ± 6.3 years), we collected 30 structured clinical documents and 100 paired imaging series (optical coherence tomography, fundus fluorescein angiography, scanning laser ophthalmoscopy, and ocular/superficial B-scan ultrasonography). Texts were semantically annotated and mapped to standardized ontologies, while images underwent rigorous DICOM-based quality control, lesion segmentation, and quantitative biomarker extraction. A domain-specific ophthalmic knowledge graph encoded causal disease and treatment relationships, enabling neuro-symbolic reasoning to constrain and guide neural feature learning. An LLM fine-tuned on ophthalmology literature and electronic health records ingested structured biomarkers and longitudinal clinical narratives through multimodal clinical-profile prompts, producing natural-language risk explanations with explicit evidence citations. On an independent test set, the hybrid model achieved AUROC 0.94 ± 0.03, AUPRC 0.92 ± 0.04, and a Brier score of 0.07, significantly outperforming purely neural and classical Cox regression baselines (p ≤ 0.01). Explainability metrics showed that >85% of predictions were supported by high-confidence knowledge-graph rules, and >90% of generated narratives accurately cited key biomarkers. A detailed case study demonstrated real-time, individualized risk stratification—for example, predicting an >70% probability of requiring three or more anti-VEGF injections within 12 months and a ~45% risk of chronic macular edema if therapy lapsed—with predictions matching the observed clinical course. These results highlight the framework’s ability to integrate multimodal evidence, provide transparent causal reasoning, and support personalized treatment planning. While limited by single-center scope and short-term follow-up, this work establishes a scalable, privacy-aware, and regulator-ready template for explainable, next-generation decision support in AMD management, with potential for expansion to larger, device-diverse cohorts and other complex retinal diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Macular DegenerationLarge Language ModelsTreatment OutcomeHumansMaleFemaleMiddle AgedAgedPrognosis

Stichwörter der Autor:innen

age-related macular degenerationexplainable artificial intelligencelarge language model (LLM)multimodal ophthalmic imagingneuro-symbolic artificial intelligencepersonalized treatment planningprognosis

Autor:innen und Institutionen

  • Zhuhai People's Hospital (The Affiliated Hospital of Beijing Institute of Technology, Zhuhai Clinical Medical College of Jinan University), Zhuhai 519000, China.
  • The Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong 999077, China.
  • Zhuhai Institute of Advanced Technology Chinese Academy of Sciences, Zhuhai 519000, China.

ORCID-Profile: Mini Han Wang

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Wang, M. H. (2025). Explainable Artificial Intelligence Framework for Predicting Treatment Outcomes in Age-Related Macular Degeneration. Sensors, 25(22), 6879. https://doi.org/10.3390/s25226879

Vancouver

Wang MH. Explainable Artificial Intelligence Framework for Predicting Treatment Outcomes in Age-Related Macular Degeneration. Sensors. 2025;25(22):6879. doi:10.3390/s25226879

BibTeX
@article{Wang2025,
  author = {Wang, Mini Han},
  title = {Explainable Artificial Intelligence Framework for Predicting Treatment Outcomes in Age-Related Macular Degeneration},
  journal = {Sensors},
  year = {2025},
  volume = {25},
  number = {22},
  pages = {6879},
  doi = {10.3390/s25226879}
}
Kostenlos starten →